Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Targets identified from exercised heart: killing multiple birds with one stone

Abstract

Cardiovascular diseases (CVDs) are a major cause of mortality worldwide, which are mainly driven by factors such as aging, sedentary lifestyle, and excess alcohol use. Exercise targets several molecules and protects hearts against many of these physiological and pathological stimuli. Accordingly, it is widely recognized as an effective therapeutic strategy for CVD. To investigate the molecular mechanism of exercise in cardiac protection, we identify and describe several crucial targets identified from exercised hearts. These targets include insulin-like growth factor 1 (IGF1)-phosphatidylinositol 3 phosphate kinase (PI3K)/protein kinase B (AKT), transcription factor CCAAT/enhancer-binding protein β (C/EBPβ), cardiac microRNAs (miRNAs, miR-222 and miR-17-3p etc.), exosomal-miRNAs (miR-342, miR-29, etc.), Sirtuin 1 (SIRT1), and nuclear factor erythroid 2‑related factor/metallothioneins (Nrf2/Mts). Targets identified from exercised hearts can alleviate injury via multiple avenues, including: (1) promoting cardiomyocyte proliferation; (2) facilitating cardiomyocyte growth and physiologic hypertrophy; (3) elevating the anti-apoptotic capacity of cardiomyocytes; (4) improving vascular endothelial function; (5) inhibiting pathological remodeling and fibrosis; (6) promoting extracellular vesicles (EVs) production and exosomal-molecules transfer. Exercise is one treatment (‘stone’), which is cardioprotective via multiple avenues (‘birds’), and is considered ‘killing multiple birds with one stone’ in this review. Further, we discuss the potential application of EV cargos in CVD treatment. We provide an outline of targets identified from the exercised heart and their mechanisms, as well as novel ideas for CVD treatment, which may provide novel direction for preclinical trials in cardiac rehabilitation.

Cardiovascular diseases (CVDs) have become a leading cause of death worldwide. In 2016, over three-quarters of death caused by CVD were heart attack and stroke, specifically. Several factors contribute to the increasing incidence of heart attack and stroke, including a sedentary lifestyle, cigarette smoking, and air pollution, etc.1,2,3,4,5,6. Thus, it is a vast and difficult challenge to prevent and treat CVDs. Exercise, however, benefits heart and reduces the risk of CVDs such as ischemic heart disease7, coronary heart disease8,9,10 and heart failure11,12,13,14. Therefore, aerobic exercise is a primary recommendation for prevention of CVD and for clinical rehabilitation. Notably, not only rehabilitation exercise training, but also voluntary physical activity significantly improves cardiac function15,16. Physical capacity and exercise tolerance have even been demonstrated to be a prognostic factor for the patient outcomes in CVD14,17,18. Strenuous exercise or high-intensity endurance exercise may induce underlying deleterious influence on cardiac function19,20, which is not considered here. Considerations including low physical capacity and exercise intolerance are not yet in our discussion either. In this review, exercise refers to an appropriate intensity of aerobic exercise, including treadmill running, swimming and other forms of voluntary exercise.

We thoroughly review molecular targets identified from exercised hearts as well as the mechanisms of exercise-induced cardiac protection (Fig. 1). Specific targets identified from exercised hearts include insulin-like growth factor 1 (IGF1)-phosphatidylinositol 3 phosphate kinase (PI3K)/protein kinase B (AKT) signaling, C/EBPβ-CITED4 (transcription factor CCAAT/enhancer-binding protein β-CREB-binding protein/p300-interacting transactivator with E/D-rich tail 4), cardiac miRNAs (miR-222, miR-17-3p, etc.), exosomal-microRNAs (miR-342, miR-29, etc.), SIRT1 (Sirtuin 1), and Nrf2/Mts (nuclear factor erythroid 2‑related factor/metallothioneins). Briefly, exercise promotes cardiomyocyte proliferation, physiological hypertrophy, and anti-apoptotic capacity. We also review related cell types (cardiac fibroblasts and endotheliocytes) in response to exercise. Given the potential value of extracellular vesicles (EVs) on CVDs treatment, we also discuss the benefits of exosomal-molecules in exercised hearts.

Fig. 1: Targets identified from exercised hearts protect against cardiac disorder via multiple avenues: killing multiple birds with one stone.
figure1

Specific target identified from exercised heart (IGF1-PI3K/AKT signaling, C/EBP-β-CITED4, cardiac miRNAs (miR-222, miR-17-3p, etc.), exosomal-miRNAs (miR-342, miR-29, etc.), SIRT1 and Nrf2-Mts) was ‘stone’, multiple effects of exercise on hearts were ‘birds’. Therefore, exercise protects hearts via ‘killing multiple birds with one stone’.

Exercise reduces the risk for CVDs

An effective intervention for CVD, exercise has been extensively studied. It protects the heart against cardiac disorders, such as heart failure, myocardial infarction (MI), hypertension, and insulin resistance17. (1) Exercise alleviates heart failure. An action trial with more than 3000 participants found that aerobic exercise causes a significant decrease in heart failure hospitalizations as well as decreased cardiovascular events21. (2) Exercise protects heart against MI, inhibiting the release of cardiac proinflammatory factors, which prevents pathologic changes22. Mechanistically, exercise augments the anti-apoptotic capacity and is a primary mechanism for its attenuating MI development. For example, cardiac C/EBPβ reduction as well as an increase in miR-222 contributes to blocking MI-induced cell apoptosis and, thus, pathological remodeling23. (3) Exercise intervention reduces blood pressure (BP) and attenuates hypertension24. The mechanism of exercise protecting BP is mainly associated with augmented endothelial functions25. As we discuss in part 3, exercise actives endothelial nitric oxide synthase (eNOS) which promotes nitric oxide (NO) production, and improves endothelial functions, mediating exercise-induced BP reduction. Additionally, oxidative stress in endothelial cells is also associated with exercise-induced endothelial protection26. (4) Exercise improves insulin resistance, reducing the risk for CVDs, as insulin resistance is a well-studied risk factor for CVDs according to a plethora of meta-analysis and systematic reviews. Clinically, insulin resistance is considered a better predictor of CVD events than fasting glucose levels27. Evidently, improving insulin sensitivity is beneficial to the cardiovascular health. Aerobic exercise can significantly improve insulin resistance and mitochondrial function, itself serving as an effective strategy for the treatment of metabolic syndrome28,29. Of note, the age, gender as well as exercise intensity should be considered when improving insulin resistance with exercise training. Different exercise intensity in different populations can produce different effects.

First, the effect of exercise on insulin resistance is associated with the intensity of exercise. In one study, low intensity physical exercise before each night shift did not affect glucose tolerance in rotating night shift workers30. High-intensity interval training, however, is found to significantly improve glucose homeostasis, functional capacity and body composition in healthy individuals31. A recent meta-analysis demonstrates that there is no difference in the glycemic and lipid level between resistance exercise and aerobic exercise32. Further, aerobic exercise alone or combined with resistance exercise provides similar effects on insulin sensitivity improvement in obese adolescents33. Aerobic exercise and resistance exercise combined with metformin are both effective in controlling glucose level. However, Walid found that resistance exercise is better than aerobic exercise when combined with metformin to treat the type 2 diabetes34.

Second, the protective effects of exercise vary with age and gender. For example, the young have been found to benefit more with respect to serum lipid and glucose homeostasis than the older after high-intensity exercise31. Resistance exercise-induced growth hormone and IGF1 molecular weight isoform are sex dependent35. Interestingly, Kaitlyn et al., report that the association between the exercise intensity and insulin sensitivity is also sex dependent, as it was observed that improvement of insulin sensitivity is associated with exercise intensity in obese men, but not obese women36.

Cellular adaptions in exercised hearts

In exercise-induced cardiac protection, many types of cells are physiologically altered. We examined four of these cells (cardiomyocytes, endothelial cells, cardiac fibroblasts, and immunocytes) and evaluate their changes following exercise (Fig. 2).

Fig. 2: Cellular adaptions in response to exercise.
figure2

In endothelial cells, exercise inhibits ROS (reactive oxygen species) production and promotes NO (nitric oxide) production as well as EV (extracellular vesicles) secretion. Exercise also inhibits ROS and improves antioxidative capacity of cardiac fibroblasts. Besides, exercise induces a rapid increase in macrophage and neutrophil number, whereas decrease in lymphocyte number. All these adaptions directly or nondirectly contributes to exercise-induced cardiomyocyte proliferation and physiological hypertrophy.

Cardiomyocyte

More energy consumption is required during exercise, leading to an increase in cardiac preload or afterload. Under this condition, cardiomyocytes tend to become physiologically hypertrophic (growth and proliferation) to match the increased demand. Adult cardiac physiological hypertrophy is characterized by an adaptive increase in cardiac mass as well as cardiomyocytes growth in length and width37 without collagen variation and maladaptive remodeling38. Many signaling pathways contribute to exercise-induced cardiac physiological hypertrophy, including IGF1-PI3K-AKT-C/EBPβ and miRNAs, which are discussed in section 3.

Vascular endothelial cells

Moderate aerobic exercise improves vascular endothelial function via promotion of NO/vascular endothelial growth factor (VEGF) and of antioxidant enzyme. Additionally, the induction of superoxide dismutase (SOD) and peroxidase by exercise can inhibit reactive oxidative species (ROS) production in endotheliocytes39, and can also trigger endothelial cells to secret EVs and that influence cardiac function40. In the aging population, exercise is found to promote endothelial cell health by elevating CXC chemokine receptor (CXCR4)/janus kinase (JAK-2) signaling41.

Cardiac fibroblasts

Fibroblasts play critical roles in extracellular matrix remodeling and cardiac repair under certain stimuli, whose activation can interact with cardiomyocytes and maintain the cardiac microenvironment42. When activated, the fibroblast converts to a myoblast, contributing to cardiac repair or fibrosis43. Recent evidence demonstrates that exercise activated the nuclear factor erythroid 2‑related factor (Nrf2) signaling in fibroblasts, subsequently elevating the expression of metallothioneins (Mts, including Mt1 and Mt2) and causing cardiomyocyte physiological hypertrophy44.

Immunocyte

Immunocytes are involved in exercise-induced cardiac protection. Clinical investigation indicates that circulating neutrophils and monocytes increase after exercise by promoting lymphocyte translocation to potential antigen sites in the heart. By contrast, exercise causes a significant reduction in lymphocytes number45.

Pivotal targets identified from exercised heart

IGF1-PI3K-AKT signaling pathway

The IGF1-PI3K-AKT pathway is extensively studied with respect to exercise-induced cardiomyocytes growth and hypertrophy46. IGF1 can be activated by exercise, and then binds to its receptors (IGF-1R) on cardiomyocytes, causing intracellular PI3K/AKT pathway activation. During IGF-1R recycling, tumor susceptibility gene 101 (Tsg101) is found to interact with family-interacting protein 3 (FIP3), whose combination further increased recycling. Thus, Tsg101 is identified as a novel target in exercised heart, further increasing cardiomyocyte hypertrophy. Treadmill exercise training significantly promoted the expression of Tsg101 in mice and Tsg101-deficient mice counteracted exercise-induced cardiac physiological hypertrophy47. Additionally, Akt is a target of PI3K and has 3 isoforms (AKT1, AKT2, AKT3). Of these, AKT1 is required for exercise-induced cardiac physiological hypertrophy and growth48. In cardiac-specific AKT1 transgenic mice, an 80% increase in AKT activity caused 2.2-fold increase in heart weight compared with that of control group49.

C/EBPβ

C/EBPβ, the transcription factor CCAAT/enhancer-binding protein β, is downstream of PI3K/Akt signaling, contributing to exercise-induced cardioprotection. Endurance exercise training can induce cardiomyocyte growth and proliferation, via AKT activation, and also suppresses C/EBPβ production. Inhibition of C/EBPβ in cardiomyocytes caused an increase in cell size and number, indicating that the C/EBPβ deficiency promoted the cardiomyocytes growth and proliferation50. Two axes are involved in C/EBPβ pathway in response to exercise: the C/EBPβ-CITED4 axis and the C/EBPβ-GATA4 axis (Fig. 3).

Fig. 3: MiRNAs in exercise-induced cardioprotection.
figure3

The mechanism of PI3K/AKT, C/EBP-β-CITED4, and cardiac miRNAs (miR-222, miR-17-3p) in exercise-induced cardiomyocyte hypertrophy, proliferation, and survival.

C/EBPβ-CITED4 axis

Exercise-induced CITED4 upregulation can induce cardiomyocyte growth at basal condition50. CITED4 induces physiological hypertrophy (~25%-fold of increase in heart mass) without causing pathologic changes in male and female mice51, whose upregulation significantly promoted an increase in cell surface area, proliferation markers expression (Ki67 and EdU), and cell number52. Mechanistically, cardiac CITED4-induced hypertrophy is also associated with upregulation of neuregulin-1 (NRG1)52.

C/EBPβ-GATA4 axis

GATA4 is a key regulator of cardiac hypertrophy and cardiomyocyte viability53. Exercise training causes a significant increase in cardiac GATA4 expression in MI in mice, whose elevation is cardioprotective54. Mechanistically, GATA4 deficiency upregulates the expression of proapoptotic proteins (caspase12 and Bcl6), alters FGF1 (fibroblast growth factor 1) and EGFR expression, leading to a reduced hypertrophic response53.

Cardiac microRNAs

MicroRNAs, small noncoding RNA molecules (~22 nucleotides), regulate gene expression in exercise-induced cardiomyocyte proliferation and growth. With RNA arrays or qRT-PCRs, several miRNAs have been identified from the exercised heart, such as miR-222, miR-17-3p, miR-21, and miR-12455,56. Here, we review the roles and mechanisms of miR-222 and miR-17-3p in exercise-induced cardiac physiological hypertrophy (Fig. 3).

MiR-222

MiR-222 was initially identified as a proproliferation factor in exercised mice models. To examine the microRNA profiling, microRNA arrays have been performed and revealed an increase in miR-222 content in exercised mice, which is consistent with that of the plasma of exercised heart failure patients. The elevation of miR-222 promotes cardiomyocyte growth and proliferation (Fig. 3). Interestingly, different targeted genes of miR-222 are found to exert different roles in cardiomyocyte. For example, miR-222 induces cardiomyocyte proliferation and growth via inhibition of Kip1 (p27) and homeodomain interacting protein kinase 1 (HIPK1). Genetic deletion of HIPK1 or p27 promotes cardiomyocyte physiological hypertrophy and proliferation, both mediators of exercise-induced cardiac protection. However, Homeobox Containing 1 (HMBOX1), another downstream target of miR-222, promotes cardiomyocyte growth and hypertrophy, but has little effect on the cardiomyocyte proliferation23.

MiR-17-3p

MiR-17-92 cluster is well studied and contributes to cardiomyocyte growth and proliferation57,58,59. The miR-17-92 cluster was initially reported in cancers and disorders, whose upregulation promotes cell proliferation60. Following this, investigators extensively examined the role of miR-17–92 cluster in hearts using cardiac-specifically transgene or knockout mice, finding miR-17–92-promoted cardiomyocyte proliferation in postnatal and adult hearts59. Notably, in passenger RNA of miR-17-92 cluster, miR-17-3p has been identified as a mediator for exercise-induced cardiac growth and proliferation in mice models. In exercised hearts, miR-17-3p promotes cardiomyocyte proliferation, growth, and survival, via targeting of metallopeptidase inhibitor 3 (TIMP3), which activates epidermal growth factor (EGF) receptor (EGFR), and c-Jun NH(2)-terminal kinase (JNK)/SP-157. Lastly, miR-17-3p indirectly regulates the phosphate and tension homology on chromosome ten (PTEN)/ protein kinase B (AKT) pathway, promoting cardiomyocyte cell survival.

Exosomal-microRNAs

Small EVs, or exosomes, are lipid bilayer vesicles with a diameter of 40–200 nm, secreted by most types of cells and existing in biological fluid such as bloods, urine, and saliva. Exosomes play important roles in cell-to-cell crosstalk, using their molecular cargo to communicate61,62,63. They are considered as a potential therapeutic strategy due to their immunologic inertia and stabilization61. MiRNAs in the exosomes play important roles in exercise-induced cardiac protection; known exosomes include miR-342-5p, miR-455, miR-320, miR-29, and miR-126. The mechanism of these exosomal-miRNAs in exercise-induced cardiac protection is shown in Fig. 4. Here in this section, we review function of exosomal-miR-342-5p in exercise-induced cardioprotection.

Fig. 4: Exosomal-miRNAs identified from exercised hearts.
figure4

Exercise promotes EVs and exosomal-miRNAs secretion. This figure shows the mechanism of exosomal-miR-455, miR-29, miR-342, miR-320, and miR-126 in exercise-induced cardiac protection.

Exosomal-miR-342-5p

MiR-342 is a mediator of exercise-induced cardiac protection. MiRNA sequencing reveals endothelial cell-derived exosomal-miR-342-5P undergoes a robust increase in exercised athletes and swam rats. Exercise-induced exosomal-miR-342-5P elevation improves the anti-apoptosis capacity of cardiomyocyte, mediated through inhibition of caspase 9 and cardiac c-Jun N-terminal kinase (JNK2)64 (Fig. 5). Also, a recent study in exercised healthy subjects showed that exercise dramatically induced 12 exosomal-miRNAs (miR-1-3p, -208a-3p, -486-5p, -23a-3p, -23b-3p, -451a, -16-5p, 378a-5p, -126-3p, -150-5p, -222-3p, and -186-5p) increased in the exosome fraction65.

Fig. 5: Crosstalk between noncardiomyocyte and cardiomyocytes in exercise-induced cardiac protection.
figure5

Exercise promotes the expression of exosomal-nuclear factor-erythroid 2 related factor 2 (Nrf2)/metallothioneins (Mts) in cardiac fibroblasts, inhibiting cardiomyocyte reactive oxidative species (ROS) production and cell apoptosis. Endotheliocytes produce EVs (containing miR-342-5p) and deliver to cardiomyocyte, leading to an increase in the antiapoptosis capacity via inhibiting caspase 9 as well as c-Jun N-terminal kinase (JNK2).

SIRT1 signaling

Exercise significantly increases SIRT1 expression66. SIRT1, one of the members of the sirtuin protein family, is an enzyme responsible for protein deacetylation, endoplasmic reticulum (ER) stress, oxidative stress, and energy metabolism. Increasing studies demonstrate that SIRT1 is involved in exercise-induced cardiac protection by alleviating adverse cardiac remodeling67 and reducing cell apoptosis68. Mechanistically, SIRT1 plays protective roles via (1) peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) activation, (2) eukaryotic initiation factor (eIF2α) pathway inactivation, and (3) forkhead boxo1 (FOXO1) reduction. First, SIRT1/PGC-1α signaling pathway activation can promote cell survival69. Exercise training upregulates SIRT1/PGC-1α/AMPK (AMP-activated protein kinase) and prolongs cell longevity70. Second, SIRT1 can attenuate ER stress-induced heart injury and cell apoptosis by interacting with eIF2α and inducing deacetylation of the lysine site (K141 and K143), which leads to protein kinase R-like endoplasmic reticulum kinase (PERK)/ eIF2α pathway inactivation71. Third, SIRT pathway activation regulates the deacetylation of FOXO1 and alleviates oxidative stress72.

Nrf2-dependent pathway

Nrf2, a transcriptional regulator, has a central rols in antioxidative response by regulating more than 200 antioxidant genes such as NAD(P)H quinone oxidoreductase 1 (NQO1), glutathione-S-transferases (GSTs) and hemeoxygenase 1 (HO-1)73. When activated by stress and, notably, exercise, Nrf2 can translocate from cytoplasm to nucleus and trigger cytoprotective gene expression, thereby improving cardiac antioxidant capacity74 (Fig. 5). Mechanistically, ROS production promotes Nrf2 translocation and activation, leading to nuclear Nrf2 accumulation in the exercised mice heart. Consistently, one study reveals that exercise activates Nrf2 signaling in the exercised young person, thereby elevating the expression of antioxidant genes such as HO-1, NAD(P)H75. The content of Nrf2 activation is associated with the intensity of exercise, whose activation has different adaptions in different exercise protocols.

The mechanism of exercise-induced cardiac protection

Exercise induces several cellular adaptions, including proliferation and physiological hypertrophy of cardiomyocytes, antioxidation of myoblasts, production of endothelial NO, and a number changes in immunocytes. In this section, we review the mechanisms by which these adaptations are cardioprotective (Fig. 6).

Fig. 6: The targets identified from exercised hearts and their mechanism: killing multiple birds with one stone.
figure6

In this section, we give an insight on exercise-induced cardioprotection, which includes (1) promoting cardiomyocytes proliferation; (2) facilitating cardiomyocytes growth and physiologic hypertrophy; (3) elevating the anti-apoptosis capacity of cardiomyocyte; (4) promoting vascular endothelial function; (5) inhibiting pathological remodeling and fibrosis; (6) promoting EVs production and exosomal-molecular transfer to cardiomyocytes.

Exercise leads to cardiomyocyte growth and physiological hypertrophy

Myocardial hypertrophy is an adaptive response to growth factors and increased workload, and includes physiological and pathological hypertrophy. Studies exploring the effects of exercise on cardiac size and left ventricular function have demonstrated that exercise caused an increase in cardiac size and improvement in left ventricular diastolic function, which is physiological, rather than pathological, hypertrophy76. Physiological hypertrophy is a typical manifestation of the cardioprotective effects of exercise, quite different from pathologic hypertrophy77,78. The serum level of natriuretic peptides (N-terminal proatrial and probrain natriuretic peptide) are biomarkers, which allow differentiation between physiological and pathologic cardiac hypertrophy79. We propose that the molecular changes identified from exercise-induced physiological may be potential targets for prevention and treatment of CVDs. Mechanistically, the decreased fatty acid oxidation and increased glucose utilization are important molecular adaptations in response to increased workload80. We review important molecular alterations identified from exercise-induced physiological hypertrophic heart. Animal and clinical studies demonstrate that exercise training significantly improved physiological cardiomyocytes growth via activating the IGF1-PI3K/AKT pathway81, whose activation also improved the antiapoptotic capacity of cardiomyocytes. Exercise-induced IGF1-PI3K/AKT pathway activation is a crucial regulator of pressure overload-induced heart dysfunction82 and MI83. The activation of the IGF1-PI3K-AKT signaling pathway mediates exercise-induced cardiac physiological hypertrophy, whose activation may be a potential target for CVD therapy.

As one of the downstream targets of PI3K/AKT, C/EBPβ-CITED4 is also important in exercise-induced cardiac healthy growth. For example, a reduction in C/EBPβ mitigates the pressure overload-induced heart failure in mice50,84. In exercised mice, C/EBPβ deficiency inhibits NF-κB activation, thereby protecting cardiomyocytes from pathological hypertrophy85.

Functionally, physical exercise-induced physiological cardiac hypertrophy may compensate for the pathological myocardial remodeling such as MI67,86,87,88. A population study demonstrates that long-term endurance exercise caused cardiac remodeling not only in the left ventricle87, but also in the right89,90. Preclinical experiments demonstrates that voluntary exercise significantly promoted cardiac β3-Ars (β3-adrenergic receptor) expression, which is cardioprotective against ischemia reperfusion injury (IR/I). Physical exercise-induced cardiac β3-Ars elevation activates eNOS, which eventually stimulated NO production91. The β3-Ars-NO axis is a novel mechanism involves in exercise-induced cardiac healthy remodeling and protection.

Exercise promotes cardiomyocytes proliferation

Mammalian cardiomyocytes have an extremely low proliferation rate92, which gradually decreases from 1 to 0.3% at the age above 70 years in human. The renewal of cardiomyocytes is no more than 50% over a lifetime93,94. Exercise promotes the capacity of cardiac proliferation in adult mice. In one study, two months of treadmill running increases the generation of cardiomyocytes95. Recently, Ana Vujic et al. used the multi-isotope imaging mass spectrometry (MIMS) to study cardiomyocyte proliferation and found ~4.6 folds of increase in adult exercised mice95.

Several molecules are involved in exercise-induced cardiomyocyte proliferation, such as C/EBPβ, miRs, and their downstream targets. Decreased C/EBPβ, or increased miR-222, both inhibit cardiac disorder via promoting proliferation and growth. C/EBPβ was the first transcriptional factor identified from adult exercised hearts, whose reduction has been associated with exercise-induced cardiomyocyte proliferation50. CITED4, which is downstream of C/EBPβ, contributed to exercise-induced cardiac protection. Exercise elevates GATA4, CITED4, and reduces C/EBPβ in MI mice, thereby protecting against cardiac disorder. Compared with the sham group, the MI mice exhibites a higher expression of C/EBPβ. Disruption of C/EBP expression in the adult heart inhibits MI-induced neutrophil infiltration and improved cardiac function51,96. CITED4 can attenuate cardiomyocyte apoptosis and autophagy flux after IR/I injury by activating the mTORC1 pathway51,97. Additionally, microRNAs, such as miR-222, miR-342, miR-17 are involved in exercise-induced cardiac proliferation. Cardiac miR-222 targets p27, HIPK1/2 and Hmbox1 and alleviates MI-induced injury.

Interestingly, exercise-induced cardiomyocyte proliferation may vary with age. To investigate this issue, different ages of rats (juvenile, adolescent and adult) are used in a recent study that underwent treadmill running for 4 weeks. Cell number analysis shows that the juvenile group has a significant increase in cardiomyocyte number (36%), higher than the adolescent and adult group. Exercise-induced cardiomyocyte proliferation is associated with the period of life98. Investigations in zebrafish also indicated that exercise training can promote cardiomyocyte proliferation99. To build the physiological hypertrophy model, adult zebrafish (~2.5 cm in body length) swam for sum up to 13 days, inducing an increase in cardiomyocytes proliferation100. As cardiomyocyte loss is a primary cause of CVD, such as in heart failure and myocardial infarction92,101,102,103, exercise-induced cardiomyocyte proliferation may be a potential preventative and therapeutic strategy for CVD.

Notably, the cell to cell crosstalk between cardiomyocytes and noncardiomyocytes plays important roles in cardiomyocyte proliferation42. Myofibroblasts, endotheliocyte and adipocytes can secret growth factors and cytokines and promote cardiomyocyte proliferation. In large animals, the isolated sinoatrial node cells (SANCs) from guinea pig heart can promote the generation of cardiomyocytes104, and may be an area of future study.

Exercise improves the anti-apoptosis capacity of cardiomyocytes

Cardiomyocyte apoptosis is another cause of CVD105,106, which can be ameliorated by exercise intervention. In the treadmill exercise model, the apoptosis index (Bax/Bcl2, cleaved caspase 3/caspase 3) decreases after two months of running107. PI3K/AKT signaling inhibits cell apoptosis and promotes cardiomyocyte survival in exercise-induced cardiac function improvement in MI mice. Additionally, exercise inhibits TGFβ1 activation and leucocytes activation and migration, leading to an increase in anti-apoptotic capacity86. miR-222 inhibits TGFβ1 pathway (JNK, TGF-β receptor), which is cardioprotective against TAC or angiotensin II-induced remodeling and cardiac fibrosis108.

In the past decade, the association between telomerase activity and exercise training has received widespread attention. Voluntary running enhances the cardiac telomerase activity to ~2-fold of control, and caused an increase in TRF2 (telomere repeat binding factor 2) expression and p53 reduction109. Exercise also promotes the expression of telomere-protective genes and extends telomere length by activating the p38 MAPK pathway in myocardial cells110. Exercise attenuated stress-induced telomerase activity reduction and telomerase length shortening, which has been shown to prevent coronary heart disease111.

Furthermore, exercise diminishes cardiomyocyte apoptosis in an indirect way, including increased autophagy content and mitochondrial function. In doxorubicin-treated mice, endurance running exercise reduced dox-induced cell apoptosis by increasing the autophagy content containing increased LC3II and decreased p62, as well as mitochondrial autophagy112.

Exercise improves vascular endothelial function

Endothelial cells play important roles in vascular homeostasis, whose dysfunction contributes to the pathological process of CVD. Aerobic exercise promotes NO production, balancing endothelium-dependent vascular homeostasis and regulating endothelial dysfunction in patients with heart failure113 and hypertension114. NO is produced by three kinds of nitric oxide synthase (NOS) enzymes: eNOS, neuronal nitric NOS (nNOS), and inducible NOS (iNOS)115. The activation of eNOS is associated with the endothelial function. Exercise training improves local blood flow by these means116 and coronary arteries vasodilation as well117,118. However, the mechanism of eNOS or NO upregulation after exercise is unknown. A recent study demonstrates that the change of wall shear stress (WSS) induced by exercise may contribute to the increase in NO production119.

MicroRNAs regulate endothelial function in exercised hearts and become a potential diagnostic biomarker for physical capacity120. Experimental evidence has revealed that exercise has a profound effect on the circulating miRNA profile. For example, exercise causes a significant increase in cardiac miR-492 expression in aortic endothelial cells and improves endothelial cell function121. Additionally, miR-126 induced by aerobic exercises inhibits the production of endothelium-derived factors such as NO and endothelin, eventually leading to further improvement in endothelial function122.

Of note, exercise-induced cardioprotective role of circulating microRNAs is not only through improving the endothelial function, but also in directly attenuating the progression of heart diseases. Specific exercise interventions such as Chinese Tai Chi can improve the life quality and block the progression of coronary heart disease (CHD) via inhibiting miR-24 and miR-155, whose level is lower in the serum of Tai Chi exercised CHD patients than that of sedentary ones123.

Exercise inhibits fibroblast switch and cardiac fibrosis

Cardiac fibroblasts, or myofibroblasts, play integral roles in extracellular matrix degradation, repair, inflammation, and cardiac disease development42. Cardiac fibroblasts converting to myofibroblasts can lead to collagen deposition and tissue fibrosis, ultimately leading to pathological events124. Notably, cardiac fibroblasts are involved in exercise-induced cardiac growth due to their communication with cardiomyocytes78. To evaluate the effect of cardiac fibroblasts on exercise-induced cardiac growth, RNA sequencing is performed in exercised or diseased C57BL/6 mice. The transcriptional analysis demonstrates that antioxidant gene Nrf2 and metallothioneins (Mt, including Mt1 and Mt2) increase in exercised hearts, while they decrease in MI and TAC hearts. Furthermore, Mt1 and Mt2 deficiency exacerbates cardiac dysfunction in mice with MI. Mechanistically, the elevation of Mts in cardiac fibroblasts can transfer to cardiomyocytes, eventually inhibiting cardiomyocyte apoptosis44.

MiRNAs, such as miR-29, are a crucial mediator for exercise-induced physiological remodeling, leading to resistance to pathological myocardial remodeling125. MiR-29 significantly attenuates cardiac collagen deposition after MI injury via inhibition of cardiac collagen type I alpha 1 (ColIA1)126. Also, exercise attenuates cardiac fibrosis via activating the SIRT1/PGC-1α/PI3K/Akt pathway67.

Furthermore, running can protect the heart against cardiac fibrosis in female ovariectomized mice by reducing oxidative stress through 8-hydroxy-2’-deoxyguanosine, matrix metalloprotein 2 (MMP2) and collagen I/III reduction127. Of note, a low intensity of exercise still promotes the antioxidative activity of heart and improves the diastolic function of left ventricle, which is different from the function on right-ventricle128.

Exercise promotes EVs production

Considered cargo in the body, EVs contain multiple molecule types including mRNA, microRNA, DNA, and proteins, mediating a wide variety of physiological and pathological processes129,130. Exercise induces the production of extracellular vesicles both in humans and experimental animals131,132,133. Of note, EVs are secreted into system circulation by almost all kinds of cells, including cardiomyocytes, endothelial cells, and platelets40. EVs deliver miRNA and proteins from endothelial cells or fibroblasts to cardiomyocyte cells in response to exercise, thereby having some role in regulation of cardiac function. In a diabetic heart model, the exercised heart tissues, as well as serum, are collected for isolation and analysis of EVs. A microRNA profile analysis showed that exercise significantly elevated miR-29b and miR-455 with respect to the sedentary group, inhibiting the expression of matrix metalloprotein 9 (MMP9) and cardiac remodeling134. Also, miR-320 in the EVs is potent in cardiac repair, whose presence improves hyperglycemia-induced cardiac injury via HSP20 pathway activation135. Exosomal-miR-126, produced by endothelial cells, increases after exercise136. EVs derived from these endothelial progenitor cells can promote vascular angiogenesis and protect heart function by delivering miR-126 in exercised hearts137. VEGF, the potential downstream target of miR-126, promotes the activation of AKT and ERK pathways, thereby improving cell survival138.

Additionally, EVs content differs greatly with and without exercise. Quantitative proteomic analysis is performed in EVs from the serum of exercised and rested human to figure out the protein cargo composition. Results showes that more than 300 proteins are transferred into system circulation139. The proteins enclosed in EVs are associated with several processes such as glycolysis (Glucose-6-phosphate 1-dehydrogenase elevation), which is activated to meet the energy requirements of exercise. As natural EVs and its contents play central roles in crosstalk between noncardiomyocyte and cardiomyocyte, EVs emerge as a potential therapeutic strategy for CVD.

Exercise reduces metabolic disorders and transcriptional changes

With economic development, the burden of cardiometabolic risk rapidly expands and attracts much attention. Cardiometabolic disease-induced mortality including insulin resistance, type 2 diabetes mellitus, and obesity, are increasing. Wang et al., reportes a significant increase in cardiometabolic risk among Chinese adults in a recent study140. Obesity and elevated dyslipidemia in younger populations implies an increasing potential of cardiometabolic diseases. Aerobic exercise, as we have seen, can ameliorate these effects, improving insulin resistance28, glucose level141 and overweight142 and reduce the cardiometabolic risk143,144. Exercise-induced transcriptional changes are important to reducing insulin resistance, partially accomplished through the transcription of insulin resistance-related genes and mitochondrial DNA (mtDNA) (Fig. 7).

Fig. 7: The effects of exercise on insulin resistance and transcriptional changes.
figure7

Exercise improves insulin resistance via reducing obesity, improving insulin sensitivity, and glucose uptake.

Studies exploring transcriptional changes induced by exercise in skeletal muscle have shown that genes related to muscle growth and antiatrophy are significantly remodeled. Among these, ANGPTL4 (angiopoietin like 4) is regulated by exercise, whose gene expression is associated with DNA methylation145. Hu et al. analyzes gene profiles and transcriptional changes induced by exercise in resistant patients and healthy controls with exercise training. Differentially expressed genes are analyzed and reveals that alteration of insulin resistance-related genes, such as MSTN (myostatin), CFHR1 (the complement factor H related 1), PFKFB3 (6-phosphofructi-2-kinase/fructose-2,6-biphosphatase) were reversed by exercise146. In addition, transcriptional changes of genes associated with glucose metabolism are investigated during exercise, ultimately demonstrating improved glucose uptake and oxidation by increasing glucose transporter 4 (Glut4) transcription in a AMPKα-independent manner147.

Mitochondrial DNA (mtDNA) is also associated with insulin sensitivity. Tomas et al. report that insulin resistance is associated with decreased mtDNA content in adolescents148. Additionally, mtDNA copy number is considered a biomarker of glucose homeostasis and insulin sensitivity in nondiabetic woman149. Cytochrome b (Cytb) is one of these genes encoded by mtDNA, and is decreased in type 2 diabetic mice when compared to control. The dyslipidemia-induced Cytb mRNA reduction, in one study, is rescued by aerobic exercise150.

Conclusions and perspectives

In this review, we examine the cardiac benefits of exercise and summarize the key factors, and their mechanisms, in exercise-induced cardiac protection, including IGF1-PI3K/AKT signaling, C/EBP-β-CITED4, cardiac miRNAs (miR-222, miR-17-3p, etc.), exosomal-miRNAs (miR-342, miR-29, etc.), SIRT1 and Nrf2-Mts. Furthermore, we review the role of noncardiomyocytes in exercise-induced cardioprotection, including cardiac fibroblasts and endothelial cells. These cardioprotective mechanisms include the following: (1) PI3K/AKT activation which reduces C/EBP-β expression and causes CITED4 and GATA upregulation after exercise training. This ultimately leads to an increase in antiapoptotic activity and enhancement of physiological hypertrophy. (2) Increased miR-222 induces physiological hypertrophy of cardiomyocytes via inhibiting HMBOX1 expression. MiR-222 mimic supplement can promote cardiomyocyte proliferation via suppression of HIPK1/p27. (3) miR-17-3p targets TIMP3, activates EGFR/JNK/SP-1, and regulates PTEN/AKT pathway, leading to cardiomyocyte cell survival. (4) Exosomal-miR-342, produced by endotheliocytes and delivered to cardiomyocytes, can attenuate cardiomyocyte apoptosis via inhibition of caspase 9 and JNK2. (5) SIRT1 signaling promotes the antiapoptotic capacity of cardiomyocytes via inhibition of p53, oxidative stress, and eIF2α acetylation. (6) Nrf2/Mts expression, in fibroblasts, induces Mts translocation to cardiomyocytes, thereby suppressing oxidative stress in cardiomyocytes. In conclusion, targets identified from exercised heart may have therapeutic potential in cardioprotection in CVDs, ‘killing multiple birds with one stone’ (Fig. 6).

Data availability

The data that support the findings of this study are available from the corresponding author upon reasonable request.

References

  1. 1.

    Lee, I., Kim, S. & Kang, H. Lifestyle risk factors and all-cause and cardiovascular disease mortality: data from the Korean Longitudinal Study of Aging. Int. J. Environ. Res. Public Health https://doi.org/10.3390/ijerph16173040 (2019).

  2. 2.

    Pope, C. A. 3rd et al. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation 109, 71–77 (2004).

    Google Scholar 

  3. 3.

    Nansseu, J. R. et al. Prevalence of major cardiovascular disease risk factors among a group of sub-Saharan African young adults: a population-based cross-sectional study in Yaounde, Cameroon. BMJ Open 9, e029858 (2019).

    PubMed  PubMed Central  Google Scholar 

  4. 4.

    Hubert, H. B., Feinleib, M., McNamara, P. M. & Castelli, W. P. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67, 968–977 (1983).

    CAS  Google Scholar 

  5. 5.

    Stamler, J., Vaccaro, O., Neaton, J. D. & Wentworth, D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16, 434–444 (1993).

    CAS  Google Scholar 

  6. 6.

    Kannel, W. B. & McGee, D. L. Diabetes and cardiovascular disease. The Framingham study. JAMA 241, 2035–2038 (1979).

    CAS  Google Scholar 

  7. 7.

    Kyu, H. H. et al. Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013. BMJ 354, i3857 (2016).

    PubMed  PubMed Central  Google Scholar 

  8. 8.

    Wang, L., Ai, D. & Zhang, N. Exercise benefits coronary heart disease. Adv. Exp. Med. Biol. 1000, 3–7 (2017).

    CAS  Google Scholar 

  9. 9.

    Moraes-Silva, I. C., Rodrigues, B., Coelho-Junior, H. J., Feriani, D. J. & Irigoyen, M. C. Myocardial infarction and exercise training: evidence from basic science. Adv. Exp. Med. Biol. 999, 139–153 (2017).

    Google Scholar 

  10. 10.

    Marschner, R. A. et al. Short-term exercise training improves cardiac function associated to a better antioxidant response and lower type 3 iodothyronine deiodinase activity after myocardial infarction. PLoS ONE 14, e0222334 (2019).

    CAS  PubMed  PubMed Central  Google Scholar 

  11. 11.

    Stolen, T. et al. Effect of exercise training on cardiac metabolism in rats with heart failure. Scand. Cardiovasc. J. https://doi.org/10.1080/14017431.2019.1658893 (2019).

  12. 12.

    Taylor, R. S. et al. Impact of exercise rehabilitation on exercise capacity and quality-of-life in heart failure: individual participant meta-analysis. J. Am. Coll. Cardiol. 73, 1430–1443 (2019).

    Google Scholar 

  13. 13.

    Ding, R. Exercise-based rehabilitation for heart failure: clinical evidence. Adv. Exp. Med. Biol. 1000, 31–49 (2017).

    CAS  Google Scholar 

  14. 14.

    Luan, X. et al. Exercise as a prescription for patients with various diseases. J. Sport Health Sci. 8, 422–441 (2019).

    PubMed  PubMed Central  Google Scholar 

  15. 15.

    Lavie, C. J. et al. Exercise and the cardiovascular system: clinical science and cardiovascular outcomes. Circ. Res. 117, 207–219 (2015).

    CAS  PubMed  PubMed Central  Google Scholar 

  16. 16.

    Wang, L., Wang, J., Cretoiu, D., Li, G. & Xiao, J. Exercise-mediated regulation of autophagy in the cardiovascular system. J. Sport Health Sci. 9, 203–210 (2020).

    Google Scholar 

  17. 17.

    Cattadori, G., Segurini, C., Picozzi, A., Padeletti, L. & Anza, C. Exercise and heart failure: an update. ESC Heart Fail 5, 222–232 (2018).

    Google Scholar 

  18. 18.

    Schachinger, V., Britten, M. B. & Zeiher, A. M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101, 1899–1906 (2000).

    CAS  Google Scholar 

  19. 19.

    Aengevaeren, V. L. et al. Exercise-induced cardiac troponin I increase and incident mortality and cardiovascular events. Circulation 140, 804–814 (2019).

    Google Scholar 

  20. 20.

    Sanchis-Gomar, F., Perez, L. M., Joyner, M. J., Lollgen, H. & Lucia, A. Endurance exercise and the heart: friend or foe? Sports Med. 46, 459–466 (2016).

    Google Scholar 

  21. 21.

    Mediano, M. F. F. et al. Influence of baseline physical activity level on exercise training response and clinical outcomes in heart failure: the HF-ACTION trial. JACC Heart Fail 6, 1011–1019 (2018).

    PubMed  PubMed Central  Google Scholar 

  22. 22.

    Barboza, C. A. et al. Cardioprotective properties of aerobic and resistance training against myocardial infarction. Int. J. Sports Med. 37, 421–430 (2016).

    CAS  Google Scholar 

  23. 23.

    Liu, X. et al. miR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell Metab. 21, 584–595 (2015).

    CAS  PubMed  PubMed Central  Google Scholar 

  24. 24.

    Hackam, D. G. et al. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. Can. J. Cardiol. 26, 249–258 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  25. 25.

    Franzoni, F. et al. Physical activity, plasma antioxidant capacity, and endothelium-dependent vasodilation in young and older men. Am. J. Hypertens. 18, 510–516 (2005).

    CAS  Google Scholar 

  26. 26.

    Korsager Larsen, M. & Matchkov, V. V. Hypertension and physical exercise: the role of oxidative stress. Medicine 52, 19–27 (2016).

    Google Scholar 

  27. 27.

    Kodama, S. et al. Fasting and post-challenge glucose as quantitative cardiovascular risk factors: a meta-analysis. J. Atheroscler. Thromb. 19, 385–396 (2012).

    CAS  Google Scholar 

  28. 28.

    Kim, D. I. et al. Six weeks of combined aerobic and resistance exercise using outdoor exercise machines improves fitness, insulin resistance, and chemerin in the Korean elderly: A pilot randomized controlled trial. Arch. Gerontol. Geriatr. 75, 59–64 (2018).

    Google Scholar 

  29. 29.

    Hur, S., Cho, S. H., Song, B. K. & Cho, B. J. Effect of resistance exercise on serum osteoprotegerin levels and insulin resistance in middle-aged women with metabolic syndrome. Med Sci. Monit. 24, 9385–9391 (2018).

    CAS  PubMed  PubMed Central  Google Scholar 

  30. 30.

    Hannemann, J. et al. Timed physical exercise does not influence circadian rhythms and glucose tolerance in rotating night shift workers: The EuRhythDia study. Diab Vasc. Dis. Res. 17, 1479164120950616 (2020).

    CAS  PubMed  PubMed Central  Google Scholar 

  31. 31.

    Marzuca-Nassr, G. N. et al. High-intensity interval training on body composition, functional capacity and biochemical markers in healthy young versus older people. Exp. Gerontol. 141, 111096 (2020).

    CAS  Google Scholar 

  32. 32.

    Nery, C. et al. Effectiveness of resistance exercise compared to aerobic exercise without insulin therapy in patients with type 2 diabetes mellitus: a meta-analysis. Braz. J. Phys. Ther. 21, 400–415 (2017).

    PubMed  PubMed Central  Google Scholar 

  33. 33.

    Lee, S. et al. Effects of exercise modality on insulin resistance and ectopic fat in adolescents with overweight and obesity: a randomized clinical trial. J. Pediatr. 206, 91–98 (2019).

    CAS  Google Scholar 

  34. 34.

    Abdelbasset, W. K. Resistance exercise versus aerobic exercise combined with metformin therapy in the treatment of type 2 diabetes: a 12-week comparative clinical study. Endocr. Metab. Immune Disord. Drug Targets https://doi.org/10.2174/1871530320999200918143227 (2020).

  35. 35.

    Pierce, J. R. et al. Growth hormone and insulin-like growth factor-I molecular weight isoform responses to resistance exercise are sex-dependent. Front. Endocrinol. 11, 571 (2020).

    Google Scholar 

  36. 36.

    Hougham, K. A. & Ross, R. Evidence that the association between exercise intensity and insulin sensitivity is sex dependent. Appl. Physiol. Nutr. Metab. 36, 730–735 (2011).

    CAS  Google Scholar 

  37. 37.

    Nakamura, M. & Sadoshima, J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat. Rev. Cardiol. 15, 387–407 (2018).

    CAS  Google Scholar 

  38. 38.

    Schuttler, D., Clauss, S., Weckbach, L. T. & Brunner, S. Molecular mechanisms of cardiac remodeling and regeneration in physical exercise. Cells https://doi.org/10.3390/cells8101128 (2019).

  39. 39.

    Conti, V. et al. Aerobic training workload affects human endothelial cells redox homeostasis. Med. Sci. Sports Exerc. 45, 644–653 (2013).

    CAS  Google Scholar 

  40. 40.

    Brahmer, A. et al. Platelets, endothelial cells and leukocytes contribute to the exercise-triggered release of extracellular vesicles into the circulation. J. Extracell. Vesicles 8, 1615820 (2019).

    CAS  PubMed  PubMed Central  Google Scholar 

  41. 41.

    Xia, W. H. et al. Physical exercise attenuates age-associated reduction in endothelium-reparative capacity of endothelial progenitor cells by increasing CXCR4/JAK-2 signaling in healthy men. Aging Cell 11, 111–119 (2012).

    CAS  Google Scholar 

  42. 42.

    Varga, I., Kyselovic, J., Galfiova, P. & Danisovic, L. The non-cardiomyocyte cells of the heart. Their possible roles in exercise-induced cardiac regeneration and remodeling. Adv. Exp. Med. Biol. 999, 117–136 (2017).

    Google Scholar 

  43. 43.

    Wakatsuki, T., Schlessinger, J. & Elson, E. L. The biochemical response of the heart to hypertension and exercise. Trends Biochem. Sci. 29, 609–617 (2004).

    CAS  Google Scholar 

  44. 44.

    Lighthouse, J. K. et al. Exercise promotes a cardioprotective gene program in resident cardiac fibroblasts. JCI Insight https://doi.org/10.1172/jci.insight.92098 (2019).

  45. 45.

    Peake, J. M., Neubauer, O., Walsh, N. P. & Simpson, R. J. Recovery of the immune system after exercise. J. Appl. Physiol. 122, 1077–1087 (2017).

    CAS  Google Scholar 

  46. 46.

    Weeks, K. L., Bernardo, B. C., Ooi, J. Y. Y., Patterson, N. L. & McMullen, J. R. The IGF1-PI3K-Akt signaling pathway in mediating exercise-induced cardiac hypertrophy and protection. Adv. Exp. Med. Biol. 1000, 187–210 (2017).

    CAS  Google Scholar 

  47. 47.

    Essandoh, K. et al. Tsg101 positively regulates physiologic-like cardiac hypertrophy through FIP3-mediated endosomal recycling of IGF-1R. FASEB J. 33, 7451–7466 (2019).

    CAS  PubMed  PubMed Central  Google Scholar 

  48. 48.

    DeBosch, B. et al. Akt1 is required for physiological cardiac growth. Circulation 113, 2097–2104 (2006).

    CAS  Google Scholar 

  49. 49.

    Shioi, T. et al. Akt/protein kinase B promotes organ growth in transgenic mice. Mol. Cell Biol. 22, 2799–2809 (2002).

    CAS  PubMed  PubMed Central  Google Scholar 

  50. 50.

    Bostrom, P. et al. C/EBPbeta controls exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell 143, 1072–1083 (2010).

    PubMed  PubMed Central  Google Scholar 

  51. 51.

    Bezzerides, V. J. et al. CITED4 induces physiologic hypertrophy and promotes functional recovery after ischemic injury. JCI Insight https://doi.org/10.1172/jci.insight.85904 (2016).

  52. 52.

    Ryall, K. A., Bezzerides, V. J., Rosenzweig, A. & Saucerman, J. J. Phenotypic screen quantifying differential regulation of cardiac myocyte hypertrophy identifies CITED4 regulation of myocyte elongation. J. Mol. Cell Cardiol. 72, 74–84 (2014).

    CAS  PubMed  PubMed Central  Google Scholar 

  53. 53.

    Oka, T. et al. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ. Res. 98, 837–845 (2006).

    CAS  Google Scholar 

  54. 54.

    Naderi, N. et al. High-intensity interval training increase GATA4, CITED4 and c-Kit and decreases C/EBPbeta in rats after myocardial infarction. Life Sci. 221, 319–326 (2019).

    CAS  Google Scholar 

  55. 55.

    Wang, L., Lv, Y., Li, G. & Xiao, J. MicroRNAs in heart and circulation during physical exercise. J. Sport Health Sci. 7, 433–441 (2018).

    PubMed  PubMed Central  Google Scholar 

  56. 56.

    Wu, G., Zhang, X. & Gao, F. The epigenetic landscape of exercise in cardiac health and disease. J. Sport Health Sci. https://doi.org/10.1016/j.jshs.2020.12.003 (2020).

  57. 57.

    Shi, J. et al. miR-17-3p contributes to exercise-induced cardiac growth and protects against myocardial ischemia-reperfusion injury. Theranostics 7, 664–676 (2017).

    CAS  PubMed  PubMed Central  Google Scholar 

  58. 58.

    Chen, Z. et al. miR-17 regulates the proliferation and apoptosis of endothelial cells in coronary heart disease via targeting insulin-like-growth factor 1. Pathol. Res. Pract. 215, 152512 (2019).

    CAS  Google Scholar 

  59. 59.

    Chen, J. et al. mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts. Circ. Res. 112, 1557–1566 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  60. 60.

    Kasinski, A. L. & Slack, F. J. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat. Rev. Cancer 11, 849–864 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  61. 61.

    Colombo, M., Raposo, G. & Thery, C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu. Rev. Cell Dev. Biol. 30, 255–289 (2014).

    CAS  Google Scholar 

  62. 62.

    Thery, C., Amigorena, S., Raposo, G. & Clayton, A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. https://doi.org/10.1002/0471143030.cb0322s30 (2006).

  63. 63.

    Mathivanan, S., Ji, H. & Simpson, R. J. Exosomes: extracellular organelles important in intercellular communication. J. Proteomics 73, 1907–1920 (2010).

    CAS  Google Scholar 

  64. 64.

    Hou, Z. et al. Longterm exercise-derived exosomal miR-342-5p. Circ. Res. 124, 1386–1400 (2019).

    CAS  Google Scholar 

  65. 65.

    D’Souza, R. F. et al. Circulatory exosomal miRNA following intense exercise is unrelated to muscle and plasma miRNA abundances. Am. J. Physiol. Endocrinol. Metab. 315, E723–E733 (2018).

    Google Scholar 

  66. 66.

    Liao, Z. Y. et al. The effect of exercise, resveratrol or their combination on Sarcopenia in aged rats via regulation of AMPK/Sirt1 pathway. Exp. Gerontol. 98, 177–183 (2017).

    CAS  Google Scholar 

  67. 67.

    Jia, D., Hou, L., Lv, Y., Xi, L. & Tian, Z. Postinfarction exercise training alleviates cardiac dysfunction and adverse remodeling via mitochondrial biogenesis and SIRT1/PGC-1alpha/PI3K/Akt signaling. J. Cell Physiol. 234, 23705–23718 (2019).

    CAS  Google Scholar 

  68. 68.

    Lai, C. H. et al. Exercise training enhanced SIRT1 longevity signaling replaces the IGF1 survival pathway to attenuate aging-induced rat heart apoptosis. Age 36, 9706 (2014).

    PubMed  PubMed Central  Google Scholar 

  69. 69.

    Packer, M. Longevity genes, cardiac ageing, and the pathogenesis of cardiomyopathy: implications for understanding the effects of current and future treatments for heart failure. Eur. Heart J. https://doi.org/10.1093/eurheartj/ehaa360 (2020).

  70. 70.

    Asokan, S. M., Wang, T., Wang, M. F. & Lin, W. T. A novel dipeptide from potato protein hydrolysate augments the effects of exercise training against high-fat diet-induced damages in senescence-accelerated mouse-prone 8 by boosting pAMPK/SIRT1/PGC-1alpha/pFOXO3 pathway. Aging 12, 7334–7349 (2020).

    CAS  PubMed  PubMed Central  Google Scholar 

  71. 71.

    Prola, A. et al. SIRT1 protects the heart from ER stress-induced cell death through eIF2alpha deacetylation. Cell Death Differ. 24, 343–356 (2017).

    CAS  Google Scholar 

  72. 72.

    Li, X. Y., Han, X., Zhang, H. M., Tan, H. & Han, S. F. [SIRT1 signaling pathway mediated the protective effects on myocardium of rats after endurance training and acute exhaustive exercise]. Zhonghua Xin Xue Guan Bing. Za Zhi 45, 501–506 (2017).

    CAS  Google Scholar 

  73. 73.

    Copple, I. M. The Keap1-Nrf2 cell defense pathway—a promising therapeutic target? Adv. Pharmācol. 63, 43–79 (2012).

    CAS  Google Scholar 

  74. 74.

    Done, A. J. & Traustadottir, T. Nrf2 mediates redox adaptations to exercise. Redox Biol. 10, 191–199 (2016).

    CAS  PubMed  PubMed Central  Google Scholar 

  75. 75.

    Done, A. J., Gage, M. J., Nieto, N. C. & Traustadottir, T. Exercise-induced Nrf2-signaling is impaired in aging. Free Radic. Biol. Med. 96, 130–138 (2016).

    CAS  Google Scholar 

  76. 76.

    Stewart, K. J., Ouyang, P., Bacher, A. C., Lima, S. & Shapiro, E. P. Exercise effects on cardiac size and left ventricular diastolic function: relationships to changes in fitness, fatness, blood pressure and insulin resistance. Heart 92, 893–898 (2006).

    CAS  Google Scholar 

  77. 77.

    Yalcin, F. et al. Evolution of ventricular hypertrophy and myocardial mechanics in physiological and pathological hypertrophy. J. Appl Physiol. 126, 354–362 (2019).

    CAS  Google Scholar 

  78. 78.

    Lerchenmuller, C. & Rosenzweig, A. Mechanisms of exercise-induced cardiac growth. Drug Discov. Today 19, 1003–1009 (2014).

    CAS  Google Scholar 

  79. 79.

    Dunn, M. E. et al. Serum natriuretic peptides as differential biomarkers allowing for the distinction between physiologic and pathologic left ventricular hypertrophy. Toxicol. Pathol. 45, 344–352 (2017).

    CAS  Google Scholar 

  80. 80.

    Jamshidi, Y. et al. Peroxisome proliferator–activated receptor alpha gene regulates left ventricular growth in response to exercise and hypertension. Circulation 105, 950–955 (2002).

    CAS  Google Scholar 

  81. 81.

    Neri Serneri, G. G. et al. Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. Circ. Res. 89, 977–982 (2001).

    CAS  Google Scholar 

  82. 82.

    Weeks, K. L. et al. Phosphoinositide 3-kinase p110alpha is a master regulator of exercise-induced cardioprotection and PI3K gene therapy rescues cardiac dysfunction. Circ. Heart Fail 5, 523–534 (2012).

    CAS  Google Scholar 

  83. 83.

    Lee, H. W. et al. Effects of exercise training and TrkB blockade on cardiac function and BDNF-TrkB signaling postmyocardial infarction in rats. Am. J. Physiol. Heart Circ. Physiol. 315, H1821–H1834 (2018).

    CAS  Google Scholar 

  84. 84.

    Trivedi, C. M. & Epstein, J. A. Heart-healthy hypertrophy. Cell Metab. 13, 3–4 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  85. 85.

    Zou, J. et al. C/EBPbeta knockdown protects cardiomyocytes from hypertrophy via inhibition of p65-NFkappaB. Mol. Cell Endocrinol. 390, 18–25 (2014).

    CAS  Google Scholar 

  86. 86.

    Liao, Z. et al. Early moderate exercise benefits myocardial infarction healing via improvement of inflammation and ventricular remodelling in rats. J. Cell Mol. Med. https://doi.org/10.1111/jcmm.14710 (2019).

  87. 87.

    McNamara, D. A. et al. Left atrial electromechanical remodeling following 2 years of high-intensity exercise training in sedentary middle-aged adults. Circulation 139, 1507–1516 (2019).

    PubMed  PubMed Central  Google Scholar 

  88. 88.

    Zhang, Y. M. et al. The effects of different initiation time of exercise training on left ventricular remodeling and cardiopulmonary rehabilitation in patients with left ventricular dysfunction after myocardial infarction. Disabil. Rehabil. 38, 268–276 (2016).

    Google Scholar 

  89. 89.

    La Gerche, A. et al. Disproportionate exercise load and remodeling of the athlete’s right ventricle. Med. Sci. Sports Exerc. 43, 974–981 (2011).

    Google Scholar 

  90. 90.

    Aengevaeren, V. L. et al. Right heart remodeling in olympic athletes during 8 years of intensive exercise training. J. Am. Coll. Cardiol. 72, 815–817 (2018).

    Google Scholar 

  91. 91.

    Calvert, J. W. et al. Exercise protects against myocardial ischemia-reperfusion injury via stimulation of beta(3)-adrenergic receptors and increased nitric oxide signaling: role of nitrite and nitrosothiols. Circ. Res. 108, 1448–1458 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  92. 92.

    Li, J. et al. Alpha-catenins control cardiomyocyte proliferation by regulating Yap activity. Circ. Res. 116, 70–79 (2015).

    CAS  Google Scholar 

  93. 93.

    Bergmann, O. et al. Evidence for cardiomyocyte renewal in humans. Science 324, 98–102 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

  94. 94.

    Lazar, E., Sadek, H. A. & Bergmann, O. Cardiomyocyte renewal in the human heart: insights from the fall-out. Eur. Heart J. 38, 2333–2342 (2017).

    PubMed  PubMed Central  Google Scholar 

  95. 95.

    Vujic, A. et al. Exercise induces new cardiomyocyte generation in the adult mammalian heart. Nat. Commun. 9, 1659 (2018).

    PubMed  PubMed Central  Google Scholar 

  96. 96.

    Huang, G. N. et al. C/EBP transcription factors mediate epicardial activation during heart development and injury. Science 338, 1599–1603 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  97. 97.

    Ding, S. et al. C/EBPB-CITED4 in exercised heart. Adv. Exp. Med. Biol. 1000, 247–259 (2017).

    CAS  Google Scholar 

  98. 98.

    Asif, Y. et al. Sustained cardiac programming by short-term juvenile exercise training in male rats. J. Physiol. 596, 163–180 (2018).

    CAS  Google Scholar 

  99. 99.

    Poss, K. D., Wilson, L. G. & Keating, M. T. Heart regeneration in zebrafish. Science 298, 2188–2190 (2002).

    CAS  Google Scholar 

  100. 100.

    Rovira, M., Borras, D. M., Marques, I. J., Puig, C. & Planas, J. V. Physiological responses to swimming-induced exercise in the adult zebrafish regenerating heart. Front. Physiol. 9, 1362 (2018).

    PubMed  PubMed Central  Google Scholar 

  101. 101.

    Narula, J. et al. Apoptosis in myocytes in end-stage heart failure. N. Engl. J. Med. 335, 1182–1189 (1996).

    CAS  Google Scholar 

  102. 102.

    Foo, R. S., Mani, K. & Kitsis, R. N. Death begets failure in the heart. J. Clin. Invest. 115, 565–571 (2005).

    CAS  PubMed  PubMed Central  Google Scholar 

  103. 103.

    Parmacek, M. S. & Epstein, J. A. Cardiomyocyte renewal. N. Engl. J. Med. 361, 86–88 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

  104. 104.

    Kiuchi, S. et al. Cardiac pacemaker cells generate cardiomyocytes from fibroblasts in long-term cultures. Sci. Rep. 9, 15174 (2019).

    PubMed  PubMed Central  Google Scholar 

  105. 105.

    Olivetti, G. et al. Apoptosis in the failing human heart. N. Engl. J. Med. 336, 1131–1141 (1997).

    CAS  Google Scholar 

  106. 106.

    Cheedipudi, S. M. et al. Exercise restores dysregulated gene expression in a mouse model of arrhythmogenic cardiomyopathy. Cardiovasc. Res. https://doi.org/10.1093/cvr/cvz199 (2019).

  107. 107.

    Siu, P. M., Bryner, R. W., Martyn, J. K. & Alway, S. E. Apoptotic adaptations from exercise training in skeletal and cardiac muscles. FASEB J. 18, 1150–1152 (2004).

    CAS  Google Scholar 

  108. 108.

    Verjans, R. et al. MicroRNA-221/222 family counteracts myocardial fibrosis in pressure overload-induced heart failure. Hypertension 71, 280–288 (2018).

    CAS  Google Scholar 

  109. 109.

    Werner, C. et al. Effects of physical exercise on myocardial telomere-regulating proteins, survival pathways, and apoptosis. J. Am. Coll. Cardiol. 52, 470–482 (2008).

    CAS  Google Scholar 

  110. 110.

    Ludlow, A. T., Gratidao, L., Ludlow, L. W., Spangenburg, E. E. & Roth, S. M. Acute exercise activates p38 MAPK and increases the expression of telomere-protective genes in cardiac muscle. Exp. Physiol. 102, 397–410 (2017).

    CAS  PubMed  PubMed Central  Google Scholar 

  111. 111.

    Stellos, K. & Spyridopoulos, I. Exercise, telomerase activity, and cardiovascular disease prevention. Eur. Heart J. 40, 47–49 (2019).

    Google Scholar 

  112. 112.

    Lee, Y., Kwon, I., Jang, Y., Cosio-Lima, L. & Barrington, P. Endurance exercise attenuates doxorubicin-induced cardiotoxicity. Med. Sci. Sports Exerc. https://doi.org/10.1249/MSS.0000000000002094 (2019).

  113. 113.

    Hambrecht, R. et al. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 98, 2709–2715 (1998).

    CAS  Google Scholar 

  114. 114.

    Teixeira, M. et al. Regular exercise participation contributes to better proteostasis, inflammatory and vasoactive profiles in patients with hypertension. Am. J. Hypertens. https://doi.org/10.1093/ajh/hpz160 (2019).

  115. 115.

    Moncada, S., Palmer, R. M. & Higgs, E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109–142 (1991).

    CAS  Google Scholar 

  116. 116.

    Vallance, P., Collier, J. & Moncada, S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2, 997–1000 (1989).

    CAS  Google Scholar 

  117. 117.

    Sessa, W. C., Pritchard, K., Seyedi, N., Wang, J. & Hintze, T. H. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ. Res. 74, 349–353 (1994).

    CAS  Google Scholar 

  118. 118.

    Griffin, K. L., Mattox, M. L., Larkin, B. D., Laughlin, M. H. & Parker, J. L. Exercise training enhances endothelium-dependent relaxation of porcine coronary arteries distal to chronic coronary occlusion. Shock 11, 56–56 (1999).

    Google Scholar 

  119. 119.

    Wang, Y. X. et al. ROS and NO dynamics in endothelial cells exposed to exercise-induced wall shear stress. Cell Mol. Bioeng. 12, 107–120 (2019).

    CAS  Google Scholar 

  120. 120.

    Domanska-Senderowska, D. et al. MicroRNA profile and adaptive response to exercise training: a review. Int. J. Sports Med. 40, 227–235 (2019).

    CAS  Google Scholar 

  121. 121.

    Cai, Y., Xie, K. L., Zheng, F. & Liu, S. X. Aerobic exercise prevents insulin resistance through the regulation of miR-492/resistin axis in aortic endothelium. J. Cardiovasc. Transl. Res. 11, 450–458 (2018).

    Google Scholar 

  122. 122.

    Donghui, T. et al. Improvement of microvascular endothelial dysfunction induced by exercise and diet is associated with microRNA-126 in obese adolescents. Microvasc. Res. 123, 86–91 (2019).

    Google Scholar 

  123. 123.

    Li, Y., Zhang, H. & Wang, Y. Tai Chi ameliorates coronary heart disease by affecting serum levels of miR-24 and miR-155. Front. Physiol. 10, 587 (2019).

    PubMed  PubMed Central  Google Scholar 

  124. 124.

    Davis, J., Burr, A. R., Davis, G. F., Birnbaumer, L. & Molkentin, J. D. A TRPC6-dependent pathway for myofibroblast transdifferentiation and wound healing in vivo. Dev. Cell 23, 705–715 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  125. 125.

    Fernandes, T., Barauna, V. G., Negrao, C. E., Phillips, M. I. & Oliveira, E. M. Aerobic exercise training promotes physiological cardiac remodeling involving a set of microRNAs. Am. J. Physiol. Heart Circ. Physiol. 309, H543–H552 (2015).

    CAS  PubMed  PubMed Central  Google Scholar 

  126. 126.

    Dawson, K. et al. MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation. Circulation 127, 1466–1475 (2013).

    CAS  Google Scholar 

  127. 127.

    Brianezi, L. et al. Effects of physical training on the myocardium of oxariectomized LDLr knockout mice: MMP 2/9, collagen I/III, inflammation and oxidative stress. Arq. Bras. Cardiol. https://doi.org/10.5935/abc.20190223 (2019).

  128. 128.

    Nogueira-Ferreira, R. et al. One year of exercise training promotes distinct adaptations in right and left ventricle of female Sprague-Dawley rats. J. Physiol. Biochem. https://doi.org/10.1007/s13105-019-00705-4 (2019).

  129. 129.

    Raposo, G. & Stoorvogel, W. Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol. 200, 373–383 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  130. 130.

    Farooqi, A. A. et al. Exosome biogenesis, bioactivities and functions as new delivery systems of natural compounds. Biotechnol. Adv. 36, 328–334 (2018).

    CAS  Google Scholar 

  131. 131.

    Bei, Y. et al. Exercise-induced circulating extracellular vesicles protect against cardiac ischemia-reperfusion injury. Basic Res. Cardiol. 112, 38 (2017).

    PubMed  PubMed Central  Google Scholar 

  132. 132.

    Li, Y. et al. Exosomes mediate the beneficial effects of exercise. Adv. Exp. Med. Biol. 1000, 333–353 (2017).

    CAS  Google Scholar 

  133. 133.

    Fruhbeis, C., Helmig, S., Tug, S., Simon, P. & Kramer-Albers, E. M. Physical exercise induces rapid release of small extracellular vesicles into the circulation. J. Extracell. Vesicles 4, 28239 (2015).

    Google Scholar 

  134. 134.

    Chaturvedi, P., Kalani, A., Medina, I., Familtseva, A. & Tyagi, S. C. Cardiosome mediated regulation of MMP9 in diabetic heart: role of mir29b and mir455 in exercise. J. Cell Mol. Med. 19, 2153–2161 (2015).

    CAS  PubMed  PubMed Central  Google Scholar 

  135. 135.

    Wang, X. et al. Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells. J. Mol. Cell Cardiol. 74, 139–150 (2014).

    CAS  PubMed  PubMed Central  Google Scholar 

  136. 136.

    Wahl, P. et al. Acute effects of different exercise protocols on the circulating vascular microRNAs -16, -21, and -126 in trained subjects. Front. Physiol. 7, 643 (2016).

    PubMed  PubMed Central  Google Scholar 

  137. 137.

    Ma, C. et al. Moderate exercise enhances endothelial progenitor cell exosomes release and function. Med. Sci. Sports Exerc. 50, 2024–2032 (2018).

    Google Scholar 

  138. 138.

    Ghorbanzadeh, V. et al. Cardioprotective effect of crocin combined with voluntary exercise in rat: role of Mir-126 and Mir-210 in heart angiogenesis. Arq. Bras. Cardiol. 109, 54–62 (2017).

    CAS  PubMed  PubMed Central  Google Scholar 

  139. 139.

    Whitham, M. et al. Extracellular vesicles provide a means for tissue crosstalk during exercise. Cell Metab. 27, 237–251 (2018). e234.

    CAS  Google Scholar 

  140. 140.

    Wang, Y. et al. Six-year incidence of cardiometabolic risk factors in a population-based cohort of Chinese adults followed from 2009 to 2015. J. Am. Heart Assoc. 8, e011368 (2019).

    PubMed  PubMed Central  Google Scholar 

  141. 141.

    Motahari-Tabari, N., Ahmad Shirvani, M., Shirzad, E. A. M., Yousefi-Abdolmaleki, E. & Teimourzadeh, M. The effect of 8 weeks aerobic exercise on insulin resistance in type 2 diabetes: a randomized clinical trial. Glob. J. Health Sci. 7, 115–121 (2014).

    PubMed  PubMed Central  Google Scholar 

  142. 142.

    Ho, S. S., Dhaliwal, S. S., Hills, A. P. & Pal, S. The effect of 12 weeks of aerobic, resistance or combination exercise training on cardiovascular risk factors in the overweight and obese in a randomized trial. BMC Public Health 12, 704 (2012).

    PubMed  PubMed Central  Google Scholar 

  143. 143.

    Marc-Hernandez, A., Ruiz-Tovar, J., Aracil, A., Guillen, S. & Moya-Ramon, M. Impact of exercise on body composition and cardiometabolic risk factors in patients awaiting bariatric surgery. Obes. Surg. 29, 3891–3900 (2019).

    CAS  Google Scholar 

  144. 144.

    Lin, X. et al. Effects of exercise training on cardiorespiratory fitness and biomarkers of cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials. J. Am. Heart Assoc. https://doi.org/10.1161/JAHA.115.002014 (2015).

  145. 145.

    Laker, R. C. et al. Transcriptomic and epigenetic responses to short-term nutrient-exercise stress in humans. Sci. Rep. 7, 15134 (2017).

    CAS  PubMed  PubMed Central  Google Scholar 

  146. 146.

    Hu, Z., Zhou, L. & He, T. Potential effect of exercise in ameliorating insulin resistance at transcriptome level. J. Sports Med. Phys. Fit. 59, 116–125 (2019).

    CAS  Google Scholar 

  147. 147.

    Niu, Y. et al. Exercise-induced GLUT4 transcription via inactivation of HDAC4/5 in mouse skeletal muscle in an AMPKalpha2-dependent manner. Biochim. Biophys. Acta Mol. Basis Dis. 1863, 2372–2381 (2017).

    CAS  Google Scholar 

  148. 148.

    Gianotti, T. F. et al. A decreased mitochondrial DNA content is related to insulin resistance in adolescents. Obesity (Silver Spring) 16, 1591–1595 (2008).

    CAS  Google Scholar 

  149. 149.

    Santos, J. L. et al. Plasma lactate and leukocyte mitochondrial DNA copy number as biomarkers of insulin sensitivity in non-diabetic women. J. Physiol. Biochem. 75, 285–297 (2019).

    CAS  Google Scholar 

  150. 150.

    Benite-Ribeiro, S. A., Lucas-Lima, K. L., Jones, J. N. & Dos Santos, J. M. Transcription of mtDNA and dyslipidemia are ameliorated by aerobic exercise in type 2 diabetes. Mol. Biol. Rep. https://doi.org/10.1007/s11033-020-05725-8 (2020).

Download references

Acknowledgements

This work was supported by the grants from National Key Research and Development Project (2018YFE0113500 to J.J.X.), National Natural Science Foundation of China (82020108002 and 81911540486 to J.J.X.), Innovation Program of Shanghai Municipal Education Commission (2017-01-07-00-09-E00042 to J.J.X.), the grant from Science and Technology Commission of Shanghai Municipality (20DZ2255400 and 18410722200 to J.J.X.), the “Dawn” Program of Shanghai Education Commission (19SG34 to J.J.X.), the Sailing Program from Science and Technology Commission of Shanghai (20YF1414000 to H.Y.W.), “Chenguang Program” of Shanghai Education Development Foundation and Shanghai Municipal Education Commission (20CG46 to H.Y.W.) and National Natural Science Foundation of China (82000253 to H.Y.W.).

Author information

Affiliations

Authors

Contributions

J.X. had the idea for the article. H.W. and Y.X. performed the literature search and analysis. H.W., L.G., K.E., and J.X. drafted and critically revised the work.

Corresponding author

Correspondence to Junjie Xiao.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval

This article does not contain any studies with human participants and animals performed by any of the authors.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wang, H., Xie, Y., Guan, L. et al. Targets identified from exercised heart: killing multiple birds with one stone. npj Regen Med 6, 23 (2021). https://doi.org/10.1038/s41536-021-00128-0

Download citation

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing